Trial Profile
Double-blind, A Multicenter, Randomized, Placebo-controlled, Parallel, Phase 2 Study to Comparative Evaluate the Efficacy of N02RS1 600mg/Day, 12,00mg/Day in Korean Patients With Acute and Chronic Bronchitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2015
Price :
$35
*
At a glance
- Drugs PMK N02RS1 (Primary)
- Indications Chronic bronchitis
- Focus Adverse reactions
- Sponsors PharmaKing
- 22 Jan 2015 New trial record